Key facts
- Auxilis.ai’s last known valuation is $4.5M (Apr 2025).
- It has raised $320K; the latest was Seed Round ($320K) in Apr 2025.
- Notable investors include Genesis Ventures (Greece).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Auxilis.ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Auxilis.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Auxilis.ai
Developer of a medical administrative automation platform designed to streamline patient communication and documentation for general practices. The company's platform uses a voice-based artificial intelligence assistant to process incoming telephone calls, answer routine patient inquiries, manage appointment scheduling, update electronic health records, and automate clinical coding for medical staff, enabling primary care clinics to eliminate telephone queues and reduce the administrative burden on reception teams.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Employees
- 2
- Website
- auxilis.ai/
- Ownership
- Privately Held (backing)
Auxilis.ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Auxilis.ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Auxilis.ai in its N-PORT filings yet. We sweep new filings monthly.